Quality of life in chronic urticaria: A survey at a public university outpatient clinic, Botucatu (Brazil)

Revista da Associacao Medica Brasileira

Volumn 57, Issue 5, 2011, Pages 565-569

  Silvares, Maria Regina Cavariani ^a   Fortes, Maria Rita Parise ^a   Miot, Hélio Amante ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Angioedema; Quality of life; Quality of life index; Sickness impact profile; Urticaria

Indexed keywords

EID: 80054731667     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0104-4230(11)70114-2     Document Type: Article

References (30)

1. Zuberbier T, Oanta A, Bogacka E, Medina I, Wesel F, Uhl P et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. Allergy 2010;65:516-28.
2. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004;114:465-74; quiz 75.
3. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004;64:2515-36.
4. Schocket AL. Chronic urticaria: pathophysiology and etiology, or the what and why. Allergy Asthma Proc 2006;27:90-5.
5. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000;105:664-72.
6. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969;81:588-97.
7. Weller K, Altrichter S, Ardelean E, Krause K, Magerl M, Metz M et al. [Chronic urticaria. Prevalence, course, prognostic factors and impact]. Hautarzt 2010;61:750-7.
8. Greaves MW. Chronic urticaria. N Engl J Med 1995;332:1767-72.
9. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
10. Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004;93:142-6.
11. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004;4:8.
12. Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol 1999;141:698-702.
13. Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 2005;85:409-13.
14. Balci DD, Inandi T, Dogramaci CA, Celik E. DLQI scores in patients with keloids and hypertrophic scars: a prospective case control study. J Dtsch Dermatol Ges 2009;7:688-92.
15. Nijsten T, Meads DM, McKenna SP. Dimensionality of the dermatology life quality index (DLQI): a commentary. Acta Derm Venereol 2006;86:284-5.
16. Adaptação e validação DLQI (Dermatology Life Quality Index) para uma amostra brasileira: avaliando qualidade de vida em dermatologia. PsiqWeb, 2004. (cited 2011 Mar 15]. Available from: http://www.virtualpsy.org/psicossomatica/dermato3.html.
17. Norman GR, Streiner DL. Biostatistics. The bare essentials. 3rd ed. Shelton, Connecticut: Peoples Medical Publishing House; 2008.
18. Henderson AR. Testing experimental data for univariate normality. Clin Chim Acta 2006;366:112-29.
19. SPSS 17.0 for Windows. Statistical Package for Social Science (SPSS). Chicago: SPSS Incorporation; 2008.
20. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201.
21. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-71.
22. Silvares MR, Coelho KI, Dalben I, Lastoria JC, Abbade LP. Sociodemographic and clinical characteristics, causal factors and evolution of a group of patients with chronic urticaria-angioedema. São Paulo Med J 2007;125:281-5.
23. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005;152:861-7.
24. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001;45:S64-6.
25. Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009;64:581-8.
26. Martins BDL, Torres FN, Oliveira MLWDR. Impact on the quality of life of patients with Hansens disease: correlation between Dermatology Life Quality Index and disease status. An Bras Dermatol 2008;83:39-43.
27. Abdul Ghaffar S, Finlay AY. Moral and cost dilemma of a psoriasis patient. Br J Dermatol 2007;156:186-7.
28. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006;154:294-8.
29. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983-91.
30. Engin B, Uguz F, Yilmaz E, Ozdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008;22:36-40.